 Connection
Brian Freed to Interleukin-2
This is a "connection" page, showing publications Brian Freed has written about Interleukin-2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.778 |
|
|
|
-
Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol. 2000 Aug; 106(2):280-7.
Score: 0.153
-
Geiselhart LA, Christian T, Minnear F, Freed BM. The cigarette tar component p-benzoquinone blocks T-lymphocyte activation by inhibiting interleukin-2 production, but not CD25, ICAM-1, or LFA-1 expression. Toxicol Appl Pharmacol. 1997 Mar; 143(1):30-6.
Score: 0.120
-
Freed BM, Lempert N, Lawrence DA. Inhibition of interleukin-2 production in the human T cell line JURKAT by nonpolar maleimides. Toxicol Appl Pharmacol. 1991 Jan; 107(1):173-82.
Score: 0.079
-
Freed BM, Stevens C, Zhang G, Rosano TG, Lempert N. A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses. Transplant Proc. 1988 Apr; 20(2 Suppl 2):233-9.
Score: 0.065
-
Freed BM, Rosano TG, Quick C, Lempert N. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture. Transplant Proc. 1987 Feb; 19(1 Pt 2):1223-6.
Score: 0.060
-
Lambert C, McCue J, Portas M, Ouyang Y, Li J, Rosano TG, Lazis A, Freed BM. Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol. 2005 Oct; 116(4):916-22.
Score: 0.054
-
McCue JM, Lazis S, John Cohen J, Modiano JF, Freed BM. Hydroquinone and catechol interfere with T cell cycle entry and progression through the G1 phase. Mol Immunol. 2003 Jun; 39(16):995-1001.
Score: 0.046
-
Li Q, Aubrey MT, Christian T, Freed BM. Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catechol. Fundam Appl Toxicol. 1997 Aug; 38(2):158-65.
Score: 0.031
-
Li Q, Geiselhart L, Mittler JN, Mudzinski SP, Lawrence DA, Freed BM. Inhibition of human T lymphoblast proliferation by hydroquinone. Toxicol Appl Pharmacol. 1996 Aug; 139(2):317-23.
Score: 0.029
-
Geiselhart L, Conti DJ, Freed BM. RO 31-8220, a novel protein kinase C inhibitor, inhibits early and late T cell activation events. Transplantation. 1996 Jun 15; 61(11):1637-42.
Score: 0.029
-
Gallichio MH, Conti DJ, Lempert N, Gruber SA, Geiselhart L, Freed BM. Calcium-mediated induction of anergy in the Jurkat T-cell line. Transplant Proc. 1994 Dec; 26(6):3458-9.
Score: 0.026
-
Freed BM, Stevens C, Brooks C, Cramer S, Lempert N, Rosano TG. Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell line. Transplant Proc. 1991 Feb; 23(1 Pt 2):980-1.
Score: 0.020
-
Rosano TG, Brooks CA, Dybas MT, Cramer SM, Stevens C, Freed BM. Selection of an optimal assay method for monitoring cyclosporine therapy. Transplant Proc. 1990 Jun; 22(3):1125-8.
Score: 0.019
-
Freed BM, Lempert N, Lawrence DA. The inhibitory effects of N-ethylmaleimide, colchicine and cytochalasins on human T-cell functions. Int J Immunopharmacol. 1989; 11(5):459-65.
Score: 0.017
-
Freed BM, Patterson DA, Rapoport R, Lawrence DA, Lempert N. Inhibition of human T cell responses by hydrogen peroxide. Pharmacol Ther. 1988; 39(1-3):267-8.
Score: 0.016
-
Freed BM, Rosano TG, Lempert N. In vitro immunosuppressive properties of cyclosporine metabolites. Transplantation. 1987 Jan; 43(1):123-7.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|